China will never permit loss of ‘any piece’ of land, says Xi

Agencies
August 1, 2017

Beijing, Aug 1: Chinese President Xi Jinping issued a tough line on national sovereignty on Tuesday amid multiple territorial disputes with his country’s neighbors, saying China will never permit the loss of “any piece” of its land to outsiders.

Mr. Xi’s declaration came during a nearly one-hour speech in Beijing marking the 90th anniversary of the founding of the People’s Liberation Army, which has formed a key pillar of support for the ruling Communist Party since 1927 and is the world’s largest standing military, with 2.3 million members.

“The Chinese people treasure peace and we absolutely do not engage in invasion and expansion. However, we have the confidence to conquer all forms of invasion,” Mr. Xi told government leaders and current and retired PLA members gathered at the hulking Great Hall of the People, the seat of the legislature that sits beside Tiananmen Square.

“We absolutely will not permit any person, any organization, any political party at any time, in any form to separate any piece of Chinese territory from China,” Mr. Xi said to applause. “No one should expect us to swallow the bitter fruit of damage to our sovereignty, security and development interests.”

Mr. Xi made no reference to any specific conflicts or disputes during his address, which focused largely on the PLA’s growth from a scrappy guerrilla force fighting Chiang Kai-shek’s Nationalists and Japanese invaders into one of the world’s most powerful, if largely untested, militaries.

China has long been embroiled in a contest with Japan over the East China Sea islands, as well as with five other governments over competing claims to territory in the strategically vital South China Sea. Beijing also threatens to use force to conquer Taiwan if peaceful enticements prove insufficient. China considers the self-governing democratic island its territory.

Mr. Xi also emphasized that the military’s highest loyalty is to the ruling Communist Party, underscoring the PLA’s key role as regime preserver through crises such as the bloody suppression of 1989 pro-democracy protests at Tiananmen Square. Top Chinese leaders have consistently rejected calls to make the PLA loyal to the government and people instead.

“The people’s army will resolutely safeguard the leadership of the Chinese Communist Party and our country’s socialist system, resolutely safeguard national sovereignty, security and development interests, and resolutely safeguard regional and world peace,” Mr. Xi said.

The speech followed a parade on Sunday at a training ground on the edge of the Gobi Desert during which Mr. Xi donned fatigues and declared that the military has the “confidence and capability” to ensure China’s sovereignty, security and national interests.

Mr. Xi, who commands the PLA as chairman of the Central Military Commission, has frequently spoken of his “China Dream” to restore China to a leadership position in international affairs with a modern, far-reaching military force to match.

The parade at the Zhurihe base in Inner Mongolia featured troops and advanced weaponry, and was another forceful indication of Mr. Xi’s iron grip over the PLA and every other political power base within the party ahead of a pivotal congress this autumn that will award him a second five-year term as leader.

That followed similarly high-profile military reviews in Beijing in 2015 and Hong Kong in June. Last week, Mr. Xi bestowed newly created “Aug. 1” honors on servicemen in a further elevation of the armed forces’ stature.

Mr. Xi and his predecessors engineered a radical upgrading of the PLA’s capabilities through years of double-digit percentage increases in the defense budget, making China the world’s second-largest military spender after the United States, although growth has slowed alongside a cooling of the overall economy.

That has also spurred a global role for the PLA, which was formerly overwhelmingly preoccupied with securing China’s territorial integrity.

Alongside its blue water navy, China is building its first overseas military base in the Horn of Africa nation of Djibouti, and Chinese ships held drills last month with Russia’s navy in the Baltic Sea, more than 10,000 km (6,000 miles) from their home ports.

 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 17,2020

Paris, Apr 17: The number of coronavirus-related deaths in France has increased by 753 to 17,920 over the past 24 hours, with the total case count now standing at 108,847, Jerome Salomon, the head of the state health agency, said on Thursday.

On Wednesday, the country reported a total of 106,206 cases, including a record 1,438 new fatalities. Salomon specified that it was not the daily death toll, as the data had been compiled over the last three-day weekend.

"The total number of victims since March 1 is 17,920," Salomon said at a briefing on Thursday.
He noted that 11,060 of them had died in hospitals, and 6,860 others in social and medical-social facilities.

President Emmanuel Macron on Monday extended nationwide movement restrictions, which had been introduced due to the epidemic, until May 11. Afterwards, the country is set to gradually reopen kindergartens, schools and universities.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 10,2020

Lahore, Jul 10: The Punjab government enforced smart lockdown in seven cities of the province for 15 days with an immediate effect from Thursday night, The News International reported.

The Primary and Secondary Healthcare Department on Thursday issued a notification under the Punjab Infectious Diseases Ordinance 2020, about enforcement of lockdown in Lahore, Multan, Faisalabad, Gujranwala, Sialkot, Gujrat and Rawalpindi, till July 24 midnight.

In Lahore, the lockdown will be enforced in A2 Block Township, EME Society, Main Bazaar Chungi Amr Sadhu, Punjab Government Servants Housing Scheme, Wapda Town, C-Block Jauhar Town and Green City.

The basic necessities of life will remain available in smart lockdown areas. "The purpose of the smart lockdown is to minimise movement of people in hotspots of positive coronavirus cases," said Capt (retd) Muhammad Usman, Secretary, Primary and Secondary Healthcare Department.

The country registered 2,751 new COVID-19 cases during the last 24 hours, taking the tally to 243,599 on Friday. The province-wise breakup includes 85,261 cases in Punjab, 100,900 cases in Sindh, 29,406 in Khyber Pakhtunkhwa, 11,099 in Balochistan, 13,829 in Islamabad, 1,619 in Gilgit-Baltistan and 1,485 in Pakistan-occupied Kashmir.

The death toll due to the virus reached 5,058 with 75 more deaths reported over the last 24 hours, as per data cited by Radio Pakistan.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.